Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Downgrades ProMetic Life Sciences (PLI:CN) (PFSCF) to Hold
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholdings
-
Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Canaccord Genuity Transfers Coverage on Zynerba Pharmaceuticals (ZYNE) at Buy
-
CannTrust (CTST) Announces Proposed $200M Common Share Offering
-
CannTrust Announces Public Offering of Common Shares
-
Wealth Closes $1.58 million Initial Tranche of Non-Brokered Private Placement
-
Brexit inertia means London's finance workers face summer slump
-
Canopy Growth Announces Plan to Acquire Leading U.S. Multi-State Cannabis Operator, Acreage Holdings
-
Greenlane Holdings (GNLN) IPO Opens 70% Higher
-
Canopy Growth (CGC) Confirms Deal to Acquire Acreage Holdings (ACRGF)
-
Canopy Growth Announces Plan to Acquire Leading U.S. Multi-State Cannabis Operator, Acreage Holdings
-
UPDATE: Greenlane Holdings Inc. (GNLN) Prices 6M Class A Shares at $17/Sh
-
Natera (NTRA) Prices 5.263M Share Follow-On Offering at $19/Sh
-
Natera Announces Pricing of Follow-On Offering
-
Greenlane Announces Pricing of Upsized Initial Public Offering
-
Turning Point Therapeutics (TPTX) IPO Opens 35% Higher
-
Qualcomm (QCOM) PT Raised to $89 at Canaccord Genuity
-
Planet 13 Holdings Inc. (PLTH:CN) (PLNHF) PT Raised to Cdn$4 at Canaccord Genuity
-
Boston Scientific (BSX) PT Lowered to $43 at Canaccord Genuity
-
Turning Point Therapeutics,Inc. (TPTX) Prices 9.25M Share IPO at $18/Sh
-
TransGlobe Energy Corporation Announces Update to Significant Shareholder
-
Turning Point Therapeutics Announces Pricing of Initial Public Offering
-
Natera (NTRA) Launches $100 Million Follow-On Offering of Common Stock
-
Natera Launches Proposed Follow-On Offering
-
Ninepoint Partners Completes Ninepoint 2019 Flow-Through Limited Partnership Initial Public Offering
-
Pre-Open Stock Movers 04/16: (ELF) (CRSP) (GH) Higher; (BRS) (WVE) (IP) Lower (more...)
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
World Class and Quadron Enter Into Arrangement Agreement
-
UPDATE: Canaccord Genuity Starts Guardant Health (GH) at Buy
-
Norvista Capital Corporation Announces Normal Course Issuer Bid
-
Waterton Sends Letter to Hudbay Shareholders Highlighting Entrenchment and Track Record of Poor Strategic Decision-Making of Hudbay's Board
-
CORRECTING and REPLACING Waterton Sends Letter to Hudbay Shareholders Highlighting Entrenchment and Track Record of Poor Strategic Decision-Making of Hudbay's Board
-
Difference Capital to Combine With Mogo Finance Technology
-
New Gold (NGD:CN) (NGD) PT Raised to $1.20 at Canaccord Genuity
-
Fortuna Silver Mines (FVI:CN) (FSM) PT Raised to Cdn$6.50 at Canaccord Genuity
-
Teck Resources Ltd (TECK-B:CN) (TECK) PT Lowered to Cdn$39 at Canaccord Genuity
-
Ivanhoe Mines Ltd. (IVN:CN) (IVPAF) PT Raised to Cdn$7.50 at Canaccord Genuity
-
Trevali Mining Corp. (TV:cN) (TREVF) PT Lowered to Cdn$0.65 at Canaccord Genuity
-
HudBay Minerals (HBM:CN) (HBM) PT Raised to Cdn$10.50 at Canaccord Genuity
-
Ero Copper Corp. (ERO:CN) (ERRPF) PT Raised to Cdn$20 at Canaccord Genuity
-
Capstone Mining Corp. (CS:CN) (CSFFF) PT Raised to Cdn$1 at Canaccord Genuity
-
Coeur d'Alene Mines (CDE) PT Lowered to $6 at Canaccord Genuity
-
Pan Am Silver (PAAS) PT Lowered to $20 at Canaccord Genuity
-
Cree (CREE) PT Raised to 'Street High' $81 at Canaccord Genuity
-
Nlight (LASR) PT Raised to $28 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $89 at Canaccord Genuity; 'Takeover Chatter Not Surprising'
-
Fibrocell Science (FCSC) Announces Pact with Castle Creek Pharma to Develop and Commercialize FCX-007 Gene Therapy
-
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy

